Real-world data on efficacy and safety of isavuconazole (ISV) are mostly based on
cohorts of patients with hematological malignancies, stem cells or solid organ transplants
(i.e., HSCT or SOT) [
[1]
,
[2]
].- DiPippo AJ
- Kontoyiannis DP
Lack of toxicity with long term isavuconazole use in patients with hematologic malignancy.
Clin Infect Dis. 2019; ([2019 Mar 7. pii: ciz159])https://doi.org/10.1093/cid/ciz159
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: an illustrative case study.Mycoses. 2018; 61: 201-205
- Lack of toxicity with long term isavuconazole use in patients with hematologic malignancy.Clin Infect Dis. 2019; ([2019 Mar 7. pii: ciz159])https://doi.org/10.1093/cid/ciz159
- Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.J Chemother. 2011; 23: 290-294
- Invasive mould infections in the ICU setting: complexities and solutions.J Antimicrob Chemother. 2017; 72: i39-i47
- European Organization for Research and Treatment of cancer/InvasiveFungal infections cooperative group. Revised definitions of invasive fungal dis- ease from the European Organization for Research and Treatment of cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases mycoses study group (EORTC/MSG) consensus group. National Institute of Allergy and Infectious Diseases mycoses study group (EORTC/MSG) consensus group.Clin Infect Dis. 2008; 46: 1813-1821
- A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients.Am J Respir Crit Care Med. 2012; 186: 56-64
- Challenges and solution of invasive Aspergillosis in non-neutropenic patients: a review.Infect Dis Ther. 2018; 7: 17-27
- Why are so many cases of invasive aspergillosis missed?.Med Mycol. 2019; 57: S94-S103
- Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.Am J Respir Crit Care Med. 2008; 177: 27-34
Article info
Publication history
Published online: September 13, 2019
Accepted:
September 9,
2019
Received:
August 23,
2019
Identification
Copyright
© 2019 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
